SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Nucleic A cid T echnology ( NAT ) testing for blood screening: impact of individual donation and M ini P ool – NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivity
16 references·0 citing·37 second hop
Nucleic A cid T echnology ( NAT ) testing for blood screening: impact of individual donation and M ini P ool – NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivity (2014)Nucleic A cid T echnology ( NAT ) testing…Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India (2014)Half a decade of mini-pool nu…Transfusion transmittable infections - Seroprevalence among blood donors in a tertiary care hospital of Delhi (2013)Transfusion transmittable inf…Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Nucleic acid testing for bloo…Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. (2013)Individual donor nucleic acid…Human immunodeficiency virus transfusion transmission despite nucleic acid testing (2013)Human immunodeficiency virus …Hemovigilance Program-India (2013)Hemovigilance Program-IndiaComparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Comparative analysis of tripl…Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 2009 (2012)Trends in prevalence, inciden…Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections (2012)Need for Nucleic Acid Testing…International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)International survey on NAT t…Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Transfusion‐associated infect…Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Refinement of a viral transmi…Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Infectivity of human immunode…Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Multicenter evaluation of ind…Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201 (2008)Comparison of the analytical …Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making (2004)Triggers for switching from m…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme (2014)Robust Postdonation Blood Screening Under Prevalence Rate Uncertainty (2017)Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations (2017)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Modeling the transmission risk of emerging infectious diseases through blood transfusion (2012)Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk (2017)Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings (2017)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)The Risk of Transfusion-Transmitted Viral Infections (1996)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes (2009)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture (2012)High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan (2003)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety (2015)Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India (2017)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience (2014)Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety (2015)Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)The Development of West Nile Virus Safety Policies by Canadian Blood Services: Guiding Principles and a Comparison Between Canada and the United States (2006)A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual‐donation testing for West Nile virus (2009)Health economics of blood transfusion safety – focus on sub-Saharan Africa (2009)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)
this work references cited by second hop

References

  • 2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
  • 2010Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress201 cited
  • 2011International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009191 cited
  • 2010Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms131 cited
  • 2008Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.73 cited
  • 2004Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making63 cited
  • 2013Comparative analysis of triplex nucleic acid test assays in United States blood donors62 cited
  • 2013Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India56 cited
  • 2008Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 20152 cited
  • 2012Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections48 cited
  • 2013Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.48 cited
  • 2013

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Hemovigilance Program-India
45 cited
  • 2012Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 200936 cited
  • 2014Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India25 cited
  • 2013Human immunodeficiency virus transfusion transmission despite nucleic acid testing24 cited
  • 2013Transfusion transmittable infections - Seroprevalence among blood donors in a tertiary care hospital of Delhi22 cited
  • Cited by

    No citing works inside the corpus for this window.